Skip to content

Clinical trials

Kidney Neoplasms trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Neoplasms Phase: Not applicable Clear all

163 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20031
20041
20052
20062
20075
20083
20095
20101
20126
20134
20147
20156
20164
201710
20186
20197
202012
202111
202211
202317
202414
202518
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48
Recruiting38
Unknown status31
Active, not recruiting16
Not yet recruiting10
Terminated10
Withdrawn9
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Bordeaux5
Dana-Farber Cancer Institute3
Hospices Civils de Lyon3
Memorial Sloan Kettering Cancer Center3
Roswell Park Cancer Institute3
Stanford University3
University Hospital, Grenoble3
Washington University School of Medicine3
Assistance Publique Hopitaux De Marseille2
Brigham and Women's Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Neoplasms163
Carcinoma, Renal Cell47
Prostatic Neoplasms35
Urinary Bladder Neoplasms25
Lung Neoplasms22
Breast Neoplasms21
Melanoma16
Neoplasms15
Pancreatic Neoplasms15
Liver Neoplasms13

Trials

Showing 51 to 75 of 163. Each trial links to its page on Pharma Observatory.

63 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.